Stay updated on Nivolumab and SRS in Recurrent Meningioma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab and SRS in Recurrent Meningioma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab and SRS in Recurrent Meningioma Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T13:32:51.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    New update dates 2026-04-08 and 2026-04-09 were added, and 2026-04-01 and 2026-04-02 were removed. This reflects chronology updates to the study record.
    Difference
    0.1%
    Check dated 2026-04-10T08:54:35.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The study record shows new update entries for 2026-04-02 and 2026-04-01 and deletions for 2026-03-25 and 2026-03-24.
    Difference
    0.1%
    Check dated 2026-04-03T05:20:56.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    Administrative updates were made to the study record dates, adding 2026-03-25 and 2026-03-24 and removing 2026-03-18 and 2026-03-19.
    Difference
    0.1%
    Check dated 2026-03-27T01:21:01.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    Added Informed Consent Form PDFs for Phase I, Phase 2A, and Phase 2B under Study Documents. The revision version is v3.5.0.
    Difference
    0.9%
    Check dated 2026-03-19T20:53:38.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    New update entries dated 2026-03-11 and 2026-03-12 for revision v3.4.3 were added, and the prior revision v3.4.2 was removed. The visible study content and page functionality appear unaffected.
    Difference
    0.1%
    Check dated 2026-03-12T20:34:04.000Z thumbnail image

Stay in the know with updates to Nivolumab and SRS in Recurrent Meningioma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab and SRS in Recurrent Meningioma Clinical Trial page.